NCT01831817View on ClinicalTrials.gov

Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity

PHASE2CompletedINTERVENTIONAL
Enrollment

140

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Dentinal Hypersensitivity
Interventions
DRUG

5% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice

Calcium sodium phosphosilicate dentifrice (5% w/w) and 1500 ppm F as sodium monofluorophosphate

DRUG

0% calcium sodium phosphosilicate/ sodium monofluorophosphate dentifrice

No calcium sodium phosphosilicate and 1500 ppm F as sodium monofluorophosphate

DRUG

Sodium monofluorophosphate dentifrice

Sodium monofluorophospate dentifrice (1000 ppm F)

DRUG

Sodium Fluoride dentifrice

Dentifrice containing 1100ppm F as sodium fluoride

Trial Locations (1)

46825

Salus Research, Inc., Fort Wayne

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01831817 - Exploratory Study to Evaluate the Efficacy of an Occlusion Based Dentifrice in Relief of Dentinal Hypersensitivity | Biotech Hunter | Biotech Hunter